Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model
Open Access
- 8 August 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1420183
Abstract
Introduction: Parkinson’s disease (PD) presents a significant challenge in medical science, as current treatments are limited to symptom management and often carry significant side effects. Our study introduces an innovative approach to evaluate the effects of gdnf overexpression mediated by CRISPRa in an in vitro model of Parkinson’s disease. The expression of gdnf can have neuroprotective effects, being related to the modulation of neuroinflammation and pathways associated with cell survival, differentiation, and growth.Methods: We have developed a targeted delivery system using a magnetite nanostructured vehicle for the efficient transport of genetic material. This system has resulted in a substantial increase, up to 200-fold) in gdnf expression in an In vitro model of Parkinson’s disease using a mixed primary culture of astrocytes, neurons, and microglia.Results and Discussion: The delivery system exhibits significant endosomal escape of more than 56%, crucial for the effective delivery and activation of the genetic material within cells. The increased gdnf expression correlates with a notable reduction in MAO-B complex activity, reaching basal values of 14.8 μU/μg of protein, and a reduction in reactive oxygen species. Additionally, there is up to a 34.6% increase in cell viability in an In vitro Parkinson’s disease model treated with the neurotoxin MPTP. Our study shows that increasing gdnf expression can remediate some of the cellular symptoms associated with Parkinson’s disease in an in vitro model of the disease using a novel nanostructured delivery system.Keywords
This publication has 102 references indexed in Scilit:
- Neurotrophic Factors in Parkinson’s Disease: Clinical Trials2024
- CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational PerspectiveAdvanced Science, 2023
- A network map of GDNF/RET signaling pathway in physiological and pathological conditionsJournal of Cell Communication and Signaling, 2023
- Magnetic and structure transition of Mn3-xFexO4 solid solutions under high-pressure and high-temperature conditionsPhysics and Chemistry of Minerals, 2022
- Maybe you can turn me on: CRISPRa-based strategies for therapeutic applicationsCellular and Molecular Life Sciences, 2022
- Characterization of Superparamagnetic/Monodisperse PEG-Coated Magnetite Nanoparticles Sonochemically Prepared from the Hematite Ore for Cd(II) Removal from Aqueous SolutionsJournal of Inorganic and Organometallic Polymers and Materials, 2020
- Intracellular RET signaling pathways activated by GDNFCell and tissue research, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Fusion of Different Crosslinked Polymers Based on Dynamic Disulfide ExchangeAngewandte Chemie International Edition, 2019
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016